Jubilant Life receives ANDA approval for Tizanidine Hydrochloride capsules

Jubilant Life Sciences has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, has received abbreviated new drug application (ANDA) final approval for Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg, the generic version of Zanaflex® of Acorda, which is used for the management of spasticity.

August 05, 2017 / 10:38 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Jubilant receives ANDA approval for Tizanidine Hydrochloride CapsulesSource : BSE

first published: Aug 5, 2017 10:38 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347